Health Canada
- Status: approved
🇨🇦 Recombinant SARS-CoV-2 Ad5 vectored vaccine in Canada
Recombinant SARS-CoV-2 Ad5 vectored vaccine (Recombinant SARS-CoV-2 Ad5 vectored vaccine) regulatory status in Canada.
Marketing authorisation
Recombinant SARS-CoV-2 Ad5 vectored vaccine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Recombinant SARS-CoV-2 Ad5 vectored vaccine approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Recombinant SARS-CoV-2 Ad5 vectored vaccine in Canada?
Jiangsu Province Centers for Disease Control and Prevention is the originator. The local marketing authorisation holder may differ — check the official source linked above.